SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-042826
Filing Date
2005-03-04
Accepted
2005-03-04 17:09:02
Documents
12
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR ENDED 12/31/2004 d10k.htm 10-K 1230319
2 FORM OF NOTICE OF GRANT OF AWARD AND AWARD AGREEMENT dex1018.htm EX-10.18 24253
3 FORM OF NOTICE OF GRANT OF STOCK OPTIONS AND OPTION AGREEMENT dex1019.htm EX-10.19 8266
4 FORM OF NONQUALIFIED STOCK OPTION AGREEMENT dex1020.htm EX-10.20 32624
5 FINANCING AGREEMENT dex1026.htm EX-10.26 208050
6 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGSTO FIXED CHARGES dex121.htm EX-12.1 19504
7 SUBSIDIARIES OF CELL THERAPEUTICS, INC. dex211.htm EX-21.1 1242
8 CONSENT OF GRANT THORNTON LLP dex231.htm EX-23.1 2002
9 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 2309
10 CERTIFICATION OF CEO (SECTION 302) dex311.htm EX-31.1 11078
11 CERTIFICATION OF CFO (SECTION 302) dex312.htm EX-31.2 11220
12 CERTIFICATION OF CEO AND CFO (SECTION 906) dex32.htm EX-32 7026
  Complete submission text file 0001193125-05-042826.txt   1560986
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12465 | Film No.: 05661998
SIC: 2834 Pharmaceutical Preparations